Outcomes of Radioactive Iodine (131I) Therapy among Hyperthyroid patients

Objective: The present study aimed to assess the thyroid outcomes six-months after radioactive Iodine-131 therapy (RIT) among hyperthyroid patients and identify factors associated with them.
 Methods: This retrospective observational was conducted at department of Nuclear Medicine Molecular Imaging, Northwest General Hospital & Research Centre during 2013 2019. For purpose, 153 were studied retrospectively for six months RIT. data obtained from medical records. Patient baseline characteristics, clinical features, laboratory investigations, results imaging, therapeutic investigations acquired recorded in a structured questionnaire.
 Results: Out screened records patients, 19.6% became euthyroid, 9.2% remained hyperthyroid, 25.5% developed hypothyroidism observed remission rate by end 80.95%. Three post-RIT, gender RAI doses had significant effect on function. frequency higher those treated an dose ≤ 20 mCi (83.0%) than > (17%). Moreover, most receiving radioiodine euthyroid (64.5%). Similar therapy, except replaced etiologies hyperthyroidism (p=0.009).
 Conclusion: Radioactive iodine (131-I) is effective treatment hyperthyroidism. However, appropriate still debatable, as there high incidence post-therapy.
 doi: https://doi.org/10.12669/pjms.39.6.7567
 How cite this: Khan MSA, Hussain A, Ahmad S, Shah MH. Outcomes Iodine (131I) Therapy Hyperthyroid patients. Pak J Med Sci. 2023;39(6):---------. Open Access article distributed under terms Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, reproduction any medium, provided original work properly cited.